000130443 001__ 130443
000130443 005__ 20240228143434.0
000130443 0247_ $$2doi$$a10.1126/scisignal.aad3812
000130443 0247_ $$2pmid$$apmid:27117252
000130443 0247_ $$2ISSN$$a1525-8882
000130443 0247_ $$2ISSN$$a1937-9145
000130443 0247_ $$2ISSN$$a1945-0877
000130443 0247_ $$2altmetric$$aaltmetric:6973550
000130443 037__ $$aDKFZ-2017-05522
000130443 041__ $$aeng
000130443 082__ $$a500
000130443 1001_ $$0P:(DE-He78)214b6b3ec48b19485139a79ccf4e082e$$aRoth, Lise$$b0$$eFirst author$$udkfz
000130443 245__ $$aNeuropilin-1 mediates vascular permeability independently of vascular endothelial growth factor receptor-2 activation.
000130443 260__ $$aWashington, DC [u.a.]$$bAssoc.$$c2016
000130443 3367_ $$2DRIVER$$aarticle
000130443 3367_ $$2DataCite$$aOutput Types/Journal article
000130443 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1521014367_19881
000130443 3367_ $$2BibTeX$$aARTICLE
000130443 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000130443 3367_ $$00$$2EndNote$$aJournal Article
000130443 520__ $$aNeuropilin-1 (NRP1) regulates developmental and pathological angiogenesis, arteriogenesis, and vascular permeability, acting as a coreceptor for semaphorin 3A (Sema3A) and the 165-amino acid isoform of vascular endothelial growth factor A (VEGF-A165). NRP1 is also the receptor for the CendR peptides, a class of cell- and tissue-penetrating peptides with a specific R-x-x-R carboxyl-terminal motif. Because the cytoplasmic domain of NRP1 lacks catalytic activity, NRP1 is mainly thought to act through the recruitment and binding to other receptors. We report here that the NRP1 intracellular domain mediates vascular permeability. Stimulation with VEGF-A165, a ligand-blocking antibody, and a CendR peptide led to NRP1 accumulation at cell-cell contacts in endothelial cell monolayers, increased cellular permeability in vitro and vascular leakage in vivo. Biochemical analyses, VEGF receptor-2 (VEGFR-2) silencing, and the use of a specific VEGFR blocker established that the effects induced by the CendR peptide and the antibody were independent of VEGFR-2. Moreover, leakage assays in mice expressing a mutant NRP1 lacking the cytoplasmic domain revealed that this domain was required for NRP1-induced vascular permeability in vivo. Hence, these data define a vascular permeability pathway mediated by NRP1 but independent of VEGFR-2 activation.
000130443 536__ $$0G:(DE-HGF)POF3-321$$a321 - Basic Concepts (POF3-321)$$cPOF3-321$$fPOF III$$x0
000130443 588__ $$aDataset connected to CrossRef, PubMed,
000130443 7001_ $$0P:(DE-HGF)0$$aPrahst, Claudia$$b1
000130443 7001_ $$0P:(DE-He78)506e027e02bbc385e5035a83ed1d8457$$aRuckdeschel, Tina$$b2$$udkfz
000130443 7001_ $$0P:(DE-HGF)0$$aSavant, Soniya$$b3
000130443 7001_ $$0P:(DE-HGF)0$$aWeström, Simone$$b4
000130443 7001_ $$aFantin, Alessandro$$b5
000130443 7001_ $$0P:(DE-He78)4bd4c3ed040ad60f0911399e2cef032d$$aRiedel, Maria$$b6$$udkfz
000130443 7001_ $$0P:(DE-HGF)0$$aHéroult, Mélanie$$b7
000130443 7001_ $$aRuhrberg, Christiana$$b8
000130443 7001_ $$0P:(DE-He78)2e92d0ae281932fc7347d819fec36b0b$$aAugustin, Hellmut$$b9$$eLast author$$udkfz
000130443 773__ $$0PERI:(DE-600)2417226-1$$a10.1126/scisignal.aad3812$$gVol. 9, no. 425, p. ra42 - ra42$$n425$$pra42 - ra42$$tScience signaling$$v9$$x1937-9145$$y2016
000130443 909CO $$ooai:inrepo02.dkfz.de:130443$$pVDB
000130443 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)214b6b3ec48b19485139a79ccf4e082e$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000130443 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000130443 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)506e027e02bbc385e5035a83ed1d8457$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000130443 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b3$$kDKFZ
000130443 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b4$$kDKFZ
000130443 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)4bd4c3ed040ad60f0911399e2cef032d$$aDeutsches Krebsforschungszentrum$$b6$$kDKFZ
000130443 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b7$$kDKFZ
000130443 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)2e92d0ae281932fc7347d819fec36b0b$$aDeutsches Krebsforschungszentrum$$b9$$kDKFZ
000130443 9131_ $$0G:(DE-HGF)POF3-321$$1G:(DE-HGF)POF3-320$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lHerz-Kreislauf-Stoffwechselerkrankungen$$vBasic Concepts$$x0
000130443 9141_ $$y2016
000130443 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000130443 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000130443 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000130443 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bThomson Reuters Master Journal List
000130443 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000130443 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000130443 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000130443 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bSCI SIGNAL : 2015
000130443 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bSCI SIGNAL : 2015
000130443 9201_ $$0I:(DE-He78)A190-20160331$$kA190$$lVaskuläre Onkologie und Metastasierung$$x0
000130443 980__ $$ajournal
000130443 980__ $$aVDB
000130443 980__ $$aI:(DE-He78)A190-20160331
000130443 980__ $$aUNRESTRICTED